FORTREA HOLDINGS INC. Repayments of Long-Term Debt
FORTREA HOLDINGS INC. (FTRE) reported Repayments of Long-Term Debt of $75.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-02-26
- FORTREA HOLDINGS INC. repayments of long-term debt for the quarter ending 2025-12-31 was $75.70M.
- FORTREA HOLDINGS INC. repayments of long-term debt for the quarter ending 2025-09-30 was $0.00.
- FORTREA HOLDINGS INC. repayments of long-term debt for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- FORTREA HOLDINGS INC. repayments of long-term debt for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- FORTREA HOLDINGS INC. repayments of long-term debt for fiscal 2025 was $75.70M, a 84.32% decline from fiscal 2024.
- FORTREA HOLDINGS INC. repayments of long-term debt for fiscal 2024 was $482.70M, a 3034.42% increase from fiscal 2023.
- FORTREA HOLDINGS INC. repayments of long-term debt for fiscal 2023 was $15.40M.
- FORTREA HOLDINGS INC. repayments of long-term debt for fiscal 2022 was $0.00.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $75.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $75.70M derived: sum of 2 quarters · filed 2026-02-26 | $75.70M derived: sum of 3 quarters · filed 2026-02-26 | $75.70M 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $475.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $475.00M derived: sum of 3 quarters · filed 2026-02-26 | $482.70M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $475.00M derived: sum of 2 quarters · filed 2025-11-05 | $482.70M 10-Q · filed 2025-11-05 | $490.40M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $475.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $482.70M 10-Q · filed 2025-08-06 | $490.40M derived: sum of 3 quarters · filed 2026-02-26 | $498.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $7.70M 10-Q · filed 2025-05-12 | $15.40M derived: sum of 2 quarters · filed 2026-02-26 | $23.10M derived: sum of 3 quarters · filed 2026-02-26 | $23.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.40M derived: sum of 2 quarters · filed 2026-02-26 | $15.40M derived: sum of 3 quarters · filed 2026-02-26 | $15.40M 10-K · filed 2026-02-26 |
| 2023-09-30 | $7.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $7.70M derived: sum of 2 quarters · filed 2024-11-08 | $7.70M 10-Q · filed 2024-11-08 | $7.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-24 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |